Ayal Hendel Talks About CRISPR in Bubble Boy Disease
Update: 2022-06-07
Description
Dr. Ayal Hendel, a genome-editing pioneer and group leader at Bar Ilan University in Israel, was one of the first researchers to use modified synthetic sgRNA to edit primary cells with CRISPR. In this episode, Dr. Hendel shares his perspectives on the recent CRISPR advancements and his work on the bubble boy disease.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
